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 Abstract    
Background/Objectives: Ensuring the optimal level of 25-hydroxy-vitamin D (25OHD) in serum (concentration 
above 30 ng/ml) is essential for protecting the health of the mother and the developing fetus. Vitamin D plays an 
important role in maintaining proper bone structure, preventing infections, reducing the risk of premature birth and 
gestational diabetes. The aim of the study was to verify whether healthy pregnant residents of Warsaw were defi-
cient in vitamin D.
Material and methods: The material consisted of 150 serum samples of 50 healthy women in 1st, 2nd and 
3rd trimester of pregnancy. 72.7% of the sera were from women who reported taking multivitamin supplements 
containing vitamin D
3
 (71% out of that group was taking 400 IU daily). The concentration of 25OHD was measured 
using the vitamin D total assay on Elecsys 2010 automatic analyzer (Roche Diagnostics).
Results: The average serum 25OHD concentrations of 50 women in 1st, 2nd and 3rd trimester of pregnancy 
were respectively: 23.1 ng/ml, 24.8 ng/ml, and 25.1 ng/ml, with no statistically significant differences. The optimal 
levels of 25OHD (30-80 ng/ml) were found in 30.0% of samples, hypovitaminosis (20-30 ng/ml) occurred in 38.7%, 
deficiency (10-20 ng/ml) in 24.0% and severe deficiency (less than 10 ng/ml) in 7.3% of cases. Mean concentration 
of 25OHD in winter season (October 1 – March 31) was 23.6 ng/ml and in summer season (April 1 – September 
30) was 25.5 ng/ml, with no statistically significant difference. On the basis of the BMI in 1st trimester two subgroups 
were distinguished from the studied subjects:  BMI <21 (13 patients, 39 samples) and BMI >25 (14 patients, 42 
samples). Mean 25OHD concentration in these groups were 27.3 and 23.5 ng/ml respectively (p<0.05). High 
statistical significance (p<0.001) was found among the total number of samples with 25OHD deficiency and severe 
deficiency (<20 ng/ml) and samples with hypovitaminosis and optimal 25OHD level (>20 ng/ml) in these groups. 
Conclusions: Regardless of trimester and season, vitamin D below the optimal level is a common occurrence during 
pregnancy and the current level of supplementation among Polish pregnant women appears to be insufficient. Our 
data suggest that special attention should be paid to the problem of vitamin D insufficiency in overweight pregnant 
women.
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Introduction
Ensuring	 an	 optimal	 level	 of	 25-hydroxy-vitamin	 D	
(25OHD)	in	serum	(concentration	above	30	ng/ml)	and	adequate	
supplementation	of	vitamin	D,	required	in	case	of	deficiency,	is	
especially	important	during	pregnancy	due	to	the	role	vitamin	D	
plays	in	protecting	the	health	of	the	mother	and	the	developing	
fetus	 [1,	 2].	High	 demand	 for	 calcium	 increases	 its	 absorption	
in	 the	 digestive	 tract	 which	 requires	 an	 additional	 supply	 of	
vitamin	D	 for	 proper	 bone	mineralization	 of	 the	 fetus, as	well	
as	synthesis	of	calcium	binding	proteins	necessary	for	vitamin	D	
absorption. In	severe	vitamin	D	deficiency	the	fetus	may	develop	
the	rickets	in utero	with	manifestation	at	birth	[3].	There	is	also	
a	 direct	 link	 between	 the	 increased	 level	 of	 25OHD	 in	 serum	
and	the	modulation	of	immune	system	in	pregnancy,	what	may	
result	in	reducing	the	risk	of	several	types	of	diseases	related	to	
bacterial	and	viral	infections	through	the	mechanism	of	induction	
of	antimicrobial	peptides	and	proteins	(AMP)	[4].	These	include	
bacterial	 vaginosis,	 mother-to-child	 transmission	 (MCTC),	
human	immunodeficiency	virus	(HIV),	dental	caries,	pneumonia,	
severe	 sepsis,	 and	 tuberculosis	 [2,	 5,	 6].	Vitamin	D	 deficiency	
has	 been	 associated	with	 various	 complications	 for	 the	mother	
and	 the	 fetus,	 including	 preeclampsia,	 gestational	 diabetes	 and	
premature	 birth	 [7,	 8,	 9].	Vitamin	D	 supply	 varies	 in	 different	
countries	depending	on	diet	and	geographic	location.	The	Polish	
Gynecological	Society	recommends	vitamin	D	supplementation	
in	pregnant	women	[10].
It	 is	 widely	 accepted	 that	 vitamin	 D	 status	 in	 humans	 is	
best	reflected	by	the	measurement	of	serum	concentration	of	its	
25-hydroxylated	 form	 (25OHD;	 calcidiol).	 Its	 level	 accurately	
shows	mean	vitamin	D	supply	because	of	long	half-life	of	25OHD	
(two-three	 weeks)	 and	 high,	 easily	 measured	 concentration.	
Despite	the	fact	that	the	active	form	of	vitamin	D	(1,25(OH)2D,	
calcitriol)	 can	 also	 be	 measured,	 its	 short	 half-life,	 significant	
dependence	 on	 renal	 failure	 and	 low	 concentration	 in	 plasma	
(more	than	1000	times	lower	in	comparison	with	25OHD)	bring	
on	technical	challenge	and	limited	usefulness	of	its	measurement.	
The	aim	of	the	study	was	to	assess	whether	randomly	selected	
healthy	pregnant	residents	of	Warsaw	were	deficient	in	vitamin	D	
and	to	measure	the	extent	of	that	deficit.
Material and methods 
Study group
The	material	 consisted	 of	 serum	 samples	 from	 50	 healthy	
volunteers	in	1st,	2nd	and	3rd	trimesters	of	pregnancy.	All	women	
were	non-smokers,	had	no	autoimmune	thyroid	diseases	(negative	
ATPO	and	ATG)	and	goiter	(thyroid	volume	below	18	ml).	Other	
autoimmune	 diseases,	 diabetes	 and	 gestational	 diabetes	 were	
excluded	on	 the	basis	of	medical	history.	All	women	delivered	
healthy	 children	 (average	Apgar	 score	 9.91,	 average	 newborn	
weight	3472	g)	at	term	(average	term	of	pregnancy	39.6	weeks).	
72.7	 %	 of	 the	 sera	 were	 obtained	 from	 women	 who	 reported	
taking	multivitamin	supplements	containing	vitamin	D
3
.	 In	 that	
group,	 71%	 of	 women	 reported	 taking	 Feminatal	 (400	 IU	 of	
vitamin	D
3
),	13.3%	-	Prenatal	(800	IU),	2.4%	-	Elewit	(500	IU),	
0.8%	-	Prevital	(250	IU)	and	6.6%	-	Centrum	or	Falvit	(200	IU).	
None	 of	 the	women	 declared	 supplementation	with	 vitamin	D	
drops.	Characteristics	of	the	study	group	are	presented	in	Table	
I.	The	study	protocol	was	approved	by	the	Ethical	Committee	of	
the	Warsaw	Medical	University	and	written	consent	was	obtained	
from	all	patients.		
 Streszczenie 
Wprowadzenie: Zapewnienie optymalnego stężenia 25-hydroksy-witaminy D (25OHD) w surowicy kobiet ciężar-
nych jest konieczne dla ochrony zdrowia matki i dziecka. Witamina D bierze udział w tworzeniu kości, przeciwdziała 
infekcjom, zmniejsza ryzyko przedwczesnych porodów i cukrzycy ciążowej.
Celem pracy było sprawdzenie czy u zdrowych kobiet ciężarnych mieszkających w Warszawie występuje niedobór 
witaminy D.
Materiał i metody: Materiał stanowiło 150 surowic od 50 zdrowych kobiet w I, II i III trymestrze ciąży. 72,7% 
surowic pochodziło od kobiet przyjmujących preparaty wielowitaminowe zawierające witaminę D
3
 (71% z nich 
przyjmowało 400 IU witaminy D dziennie). Stężenie 25OHD mierzono testem vitamin D total na automatycznym 
analizatorze Elecsys 2010 (Roche Diagnostics).
Wyniki: Średnie stężenie 25OHD w surowicy kobiet w I, II i III trymestrze ciąży wyniosło odpowiednio: 23,1 ng/ml, 
24,8 ng/ml i 25,1 ng/ml. Optymalny poziom 25OHD zaobserwowano w 30,0% próbek, hipowitaminozę w 38,7%, 
deficyt w 24,0% oraz głęboki deficyt w 7,3% próbek. Średnie stężenie 25OHD w sezonie zimowym nie wykazywało 
statystycznie znamiennych różnic w porównaniu z sezonem letnim i wyniosło odpowiednio 23,6 ng/ml i 25,5 ng/ml. 
U kobiet z BMI w I trymestrze ciąży <21 kg/m2 (13 pacjentek, 39 próbek) i BMI >25 kg/m2 (14 pacjentek, 42 próbek) 
średnie stężenie 25OHD wyniosło odpowiednio 27,3 ng/ml i 23,5 ng/ml. W tych grupach zaobserwowano wyso-
ką znamienność statystyczną (p<0.001) pomiędzy całkowitą liczbą próbek z deficytem oraz głębokim deficytem 
25OHD (<20 ng/ml) w porównaniu z liczbą próbek z hipowitaminozą i optymalnym poziomem 25OHD (>20 ng/ml).
Wnioski: Niezależnie od trymestru oraz pory roku stężenia witaminy D poniżej poziomu optymalnego jest częste 
wśród kobiet ciężarnych w Polsce a obecnie stosowany poziom suplementacji wydaje się niewystarczający. Nasze 
wyniki sugerują, że większą uwagę należy zwrócić na problem niedoboru witaminy D wśród kobiet ciężarnych 
z nadwagą.
 Słowa kluczowe: niedobór witaminy D / kalcydiol / ciąża /
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Biochemical measurements 
Fasting	 blood	 samples	 were	 collected	 between	 7:30	 and	
9:30	am.	Samples	for	biochemical	determinations	were	routinely	
centrifuged	and	serum	was	kept	frozen	at	–20ºC	until	quantitative	
assay.	 The	 concentration	 of	 25OHD	 was	 measured	 using	 the	
vitamin	D	total	assay	on	Elecsys	2010	automatic	analyzer	(Roche	
Diagnostics).	
Vitamin D status
According	to	Polish	terminology,	vitamin	D	supply	in	adults,	
based	on	serum	25OHD	concentration,	can	be	divided	 into	 the	
following	 categories:	 severe	 deficiency	 (<10	 ng/ml),	 medium	
deficiency	 (10-20	 ng/ml),	 hypovitaminosis	 D	 (20-30	 ng/ml),	
recommended	 or	 optimum	 level	 (30-80	 ng/ml)	 and	 toxic	 level	
(>100	 ng/ml)	 [11,	 12].	 These	 categories	 differ	 slightly	 from	
the	 World	 Health	 Organization	 and	 American	 and	 Canadian	
classification,	where	levels	below	10	ng/ml	(USA)	or	below	20	
ng/ml	 (Canada)	were	 considered	deficient	 and	 levels	 below	30	
ng/ml	were	classified	as	insufficient.	An	optimal	level	is	typically	
defined	as	serum	25OHD	level	between	30-76	ng/ml	[13-15].
Statistical analysis
Statistical	 analysis	was	performed	by	Statistica	 version	10	
(StatSoft).	Parametric	 t-Student’s	 and	non-parametric	U	Mann-
Whitney	 tests	were	 used	 to	 compare	 the	 quantitative	 variables	
between	 two	 independent	 groups.	 V-square	 test	 was	 used	
for	 distribution	 analysis.	 p<0.05	 was	 considered	 statistically	
significant.	
Results 
25OHD	 concentration	 in	 150	 serum	 samples	 from	 50	
healthy	 pregnant	 women	 were	 measured	 (Table	 II).	 The	
average	 concentrations	 of	 serum	 25OHD	 in	 1st,	 2nd	 and	 3rd 
trimester	 were	 respectively:	 23.1	 ng/ml,	 24.8	 ng/ml,	 and	 25.1	
ng/ml,	 with	 no	 statistically	 significant	 differences	 between	 the	
trimesters.	Optimal	levels	of	25OHD	(30-80	ng/ml)	were	found	
in	30.0%	of	the	samples	and	the	rest	was	below	optimum	level.	
Hypovitaminosis	 (20-30	 ng/ml)	was	 observed	 in	 38.7%	 of	 the	
samples,	medium	deficiency	(10-20	ng/ml)	in	24.0%	and	severe	
deficiency	(less	than	10	ng/ml)	in	7.3%	of	cases.	28	of	50	women	
declared	taking	multivitamin	supplements	containing	vitamin	D
3
 
during	all	three	trimesters	of	pregnancy,	four	women	did	not	use	
vitamins	 in	 pregnancy	 and	 nine	 reported	 supplementation	 only	
during	one	of	the	trimesters.	Average	concentrations	of	25OHD	
in	 samples	 taken	 from	women	 declaring	 supplementation	with	
multivitamin	containing	vitamin	D
3
	in	the	1st,	2nd	and	3rd	trimester	
were	 23.4,	 25.1	 and	 26.6	 ng/ml,	 respectively,	 and	 in	 samples	
from	 women	 using	 no	 multivitamin	 pills	 22.0,	 24.1	 and	 22.1	
ng/ml,	 respectively,	 with	 no	 statistically	 significant	 difference.	
Mean	 concentration	 of	 25OHD	 during	winter	 season	 (October	
1	–	March	31)	was	23.6	ng/ml	and	in	summer	season	(April	1	–	
September	30)	it	was	25.5	ng/ml,	with	no	statistically	significant	
difference	(Table	III).
Two	 subgroups	 were	 selected	 from	 the	 studied	 subjects	
according	to	BMI	in	the	1st	trimester:	with	the	lowest	BMI	(<21;	
13	 patients,	 39	 samples)	 and	 with	 the	 highest	 BMI	 (>25;	 14	
patients,	42	samples)	(Table	IV).	
The	discrepancy	 in	body	mass	between	both	groups	 lasted	
to	the	end	of	the	pregnancy	–	the	weight	gains	between	the	first	
visit	 and	2nd	 and	3rd	 trimesters	observed	 in	 low-BMI	and	high-
BMI	groups	were	higher	in	the	high-BMI	group	(mean	4.5	and	
10.3	kg	versus	3.5	and	7.9	kg	in	low-BMI	group).	Mean	25OHD	
concentrations	in	these	groups	were	significantly	different	(27.3	
and	 23.5	 ng/ml	 respectively;	 p<0.05).	Much	 higher	 percentage	
of	optimal	25OHD	results	(35.9%)	was	found	for	low-BMI	than	
for	high-BMI	women	(23.8%).	Severe	deficiency	was	observed	
in	 none	 of	 the	 39	 samples	 coming	 from	 the	 low-BMI	women	
and	five	of	 the	42	 samples	 (11.9%)	 from	 the	high-BMI	group.	
High	statistical	significance	(p<0.001)	was	found	among	the	total	
number	of	samples	with	25OHD	deficiency	and	severe	deficiency	
(<20	 ng/ml)	 and	 samples	 with	 hypovitaminosis	 and	 optimal	
25OHD	level	(>20	ng/ml)	in	these	group.
Discussion 
Although	 the	 optimal	 serum	 level	 of	 25OHD	 for	 adults	
is	 above	 30	 ng/ml,	 according	 to	 international	 and	 Polish	
recommendations,	 population	 studies	 indicate	 that	 vitamin	 D	
insufficiency	 is	 a	 global	 epidemic	 [16,	 17].	 The	 prevalence	 of	
vitamin	 D	 deficiency	 in	 the	 Polish	 population	 remains	 largely	
unknown.	Our	results,	coming	from	a	group	of	healthy	pregnant	
volunteers	living	in	Warsaw,	indicate	that	vitamin	D	insufficiency	
affected	 70%	 of	 the	 studied	 individuals	 and	 average	 25OHD	
serum	concentration	was	24.4	ng/ml	(Table	II).	
During	 pregnancy	 vitamin	 D	 demand	 is	 even	 higher	 than	
for	 non-pregnant	women,	 due	 to	 growing	 needs	 of	 the	mother	
and	 the	 child	 [1,	 3].	 Thus,	 it	 is	 unsurprising	 that	 vitamin	 D	
supplementation	 is	 highly	 necessary	 and	 vitamin	 supplements	
containing	vitamin	D
3
	or	D2 are	most	recommended	to	pregnant	
women.	92%	of	our	patients	declared	taking	vitamin	supplements	
during	pregnancy	(about	400	IU	D
3
	daily),	but	only	half	of	them	
did	 it	 regularly	 throughout	 the	 entire	pregnancy	and	about	one	
fourth	of	the	women	did	not	use	vitamin	supplementation	or	used	
it	only	incidentally.	Our	results	clearly	indicate	that,	regardless	of	
gestation	length	and	season,	 the	 level	of	supplementation	has	a	
minor	effect	on	vitamin	D	status	which	is	still	below	the	optimum	
level	(Table	II	and	III).	
Table I. Characteristics of the study group (n=50).
Parameter mean±sd (min-max)
Weight (kg])
       1st trimester
       2nd trimester
       3rd trimester
64.9±8.3 (49.0-87.0)
68.9±8.7 (50.5-89.0)
73.9±9.6 (53.0-93.0)
BMI (kg/m2)
       1st trimester 23.4±3.1 (18.4-32.0) 
Age (1st trimester), years 29.4±3.1 (24-37)
Percentages (%)
Vit.D supplementation
       1st trimester
       2nd trimester
       3rd trimester
80%
70%
68%
First pregnancy 52%
Second pregnancy 36%
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Current	 Polish	 recommendations	 for	 vitamin	 D	
supplementation	 during	 pregnancy	 are	 800–1000	 IU/day,	 but	
such	doses	are	 rarely	 taken	by	patients.	The	weakness	of	 these	
recommendations	 lies	 in	 the	 fact	 that	 they	 are	 based	 almost	
exclusively	on	the	results	of	authors	studying	populations	other	
than	Polish	[18,	19].	
Moreover,	multivitamin	pills	for	pregnant	women	in	Poland	
usually	contain	400	IU	of	vitamin	D
3
	or	less.	In	our	study,	71%	
of	women	reporting	taking	400	IU/day,	only	13.3%	800	IU/day	
and	none	of	 the	women	declared	doses	above	800	IU/day.	The	
suggestion	 of	 Polish	 experts	 that	 the	 optimal	 procedure	 during	
pregnancy	 and	 breastfeeding	 is	 to	 adjust	 individual	 doses	 of	
vitamin	 D	 to	 each	 patient	 [18]	 is	 not	 implemented	 in	 routine	
practice.	 The	 American	 Committee	 of	 Obstetric	 Practice	 and	
Gynecologists	 recommends	 vitamin	D	 doses	 of	 1000-2000	 IU	
daily	if	vitamin	D	deficiency	is	diagnosed	during	pregnancy	[14].	
Recent	studies	of	Hollis	et	al.,	report	that	administration	of	2000-
4000	IU	of	vitamin	D	per	day	during	the	second	and	third	trimesters	
of	 pregnancy	 causes	 substantial	 increase	 in	 serum	 25OHD	
concentration	without	hypercalcemia,	whereas	 supplementation	
with	 400	 ID/day	 has	 only	 a	 minor	 effect	 [1,	 20].	 Thus,	 these	
authors	concluded	that	current	international	recommendations	for	
vitamin	D	supplementation	during	pregnancy	should	be	raised	to	
4000	IU/day	[20].	Nevertheless,	due	to	the	absence	of	evidence	
for	 differences	 in	 clinical	 outcomes	 regarding	 vitamin	 D	 dose	
or	serum	25OHD	levels,	other	researchers	are	more	inclined	to	
postulate	 ‘more	 controlled	 trials	 with	 biologically	 meaningful	
endpoints	 determined’	 before	 the	 recommendations	 are	 revised	
[21].	
The	 question	 remains	 how	 to	 supplement	 vitamin	 D.	
Multivitamin	 supplements	 are	 probably	 not	 the	 best	 source	 of	
vitamin	D	because	the	absorption	of	hydrophobic	vitamin	D	may	
be	significantly	lower	than	the	other	vitamins	and	elements,	well-
soluble	 in	 an	 aqueous	medium	 [22].	Also,	 stability	 of	 vitamin	
D	in	multivitamin	pills	 is	unknown.	Potentially	better	absorbed	
preparations	 containing	 exclusively	 vitamin	 D	 are	 not	 widely	
used	by	patients	in	Poland.	Therefore,	it	is	necessary	to	change	
the	awareness	of	pregnant	women	by	providing	more	information	
about	the	importance	of	ensuring	optimal	levels	of	vitamin	D	for	
the	health	of	the	mother	and	the	child.	
Table II. Serum concentration of 25OHD and the percentage of results with optimal (>30 ng/ml) and insufficient levels of 25OHD in pregnant women taking multivitamin 
supplements containing vitamin D3 (vitD sup) and pregnant women without supplementation (vitD unsup). 
Parameter 1st trimester 2nd trimester 3rd trimester All trimesters
Group 
(n)
vitD 
sup
(40)
vitD 
unsup
(10)
all
(50)
vitD 
sup
(35)
vitD 
unsup
(15)
all
(50)
vitD 
sup
(34)
vitD 
unsup
(16)
all
(50)
vitD 
sup
(122)
vitD 
unsup
(43)
all
(165)
25OHD [ng/ml] 
mean
sd
min
max
23.4
9.4
7.9
47.3
22.0
5.9
7.4
31.9
23.1
8.9
7.4
47.3
25.1
9.2
8.1
44.2
24.1
9.6
6.1
40.9
24.8
9.3
6.1
44.2
26.6
10.1
7.8
49.7
22.1
10.2
3.3
37.4
25.1
10.4
3.3
49.7
24.9
9.7
7.6
49.7
22.8
9.1
3.3
40.9
24.4
9.6
3.3
49.7
25OHD [%]
>30 ng/ml
20-30 ng/ml
10-20 ng/ml
<10 ng/ml
25.0
37.5
30.0
7.5
10.0
70.0
10.0
10.0
22.0
44.0
26.0
8.0
31.4
31.7
28.6
2.9
33.3
40.0
13.3
13.3
32.0
38.0
24.0
6.0
38.2
35.3
23.5
2.9
31.3
31.3
18.8
18.8
36.0
34.0
22.0
8.0
31.2
36.7
27.5
4.6
26.8
43.9
14.6
14.6
30.0
38.7
24.0
7.3
Table III. Serum 25OHD concentration and the percentage of results with optimal (>30 ng/ml) and insufficient levels of 25OHD in the study group in the winter (October 1 –  
– March 31) and summer season (April 1 – September 30) in pregnant women taking multivitamin supplements containing vitamin D3 (vitD sup) and pregnant women without 
supplementation (vitD unsup). In brackets, the number of patients. 
Parameter
Summer Winter
vitD sup
(42)
vitD unsup
(15)
all
(57)
vitD sup
(67)
vitD unsup
(26)
all
(93)
25OHD [ng/ml] 
mean
sd
min
max
26.6
9.6
7.9
47.3
22.5
9.2
3.3
34.7
25.5
9.7
3.3
47.3
23.9
9.5
7.6
49.7
22.9
9.1
6.1
40.9
23.6
9.4
6.1
49.7
25OHD [%]
>30 ng/ml
20-30 ng/ml
10-20 ng/ml
<10 ng/ml
38.1
35.7
23.8
2.4
33.3
40.0
13.3
13.3
36.8
36.8
21.1
5.3
26,9
37.3
29.9
6.0
23.1
46.2
15.4
15.4
25.8
39.8
25.8
8.6
©  P o l s k i e  T o w a r z y s t w o  G i n e k o l o g i c z n eNr 05/2013 367
P R A C E  O R Y G I N A L N E
  położnictwo
Zbigniew Bartoszewicz et al. Vitamin D insufficiency in healthy pregnant women living in Warsaw.
Ginekol Pol. 2013, 84, 363-367  
Surprisingly,	 our	 results	 revealed	 minor	 seasonal	 changes	
of	 25OHD	 concentrations	 (25.5	 ng/ml	 in	 summer	 versus	 23.6	
ng/ml	in	winter)	that	are	difficult	to	explain	and	contrary	to	the	
reports	 in	 the	 literature	 [23].	One	 of	 the	 possible	 explanations	
could	be	the	fact	that	pregnant	women	avoid	high	sun	exposure	
in	the	summer,	between	10	am	and	2	pm,	when	the	sun	is	most	
effective	in	vitamin	D	skin	synthesis	at	this	latitude,	because	of	
their	 economic	 activity,	 often	 lasting	 to	 the	 end	 of	 pregnancy.	
Moreover,	 little	 influence	 of	 declared	 supplementation	 on	
mean	 25OHD	 concentration	 was	 noted	 (Table	 III).	 Extremely	
low	 25OHD	was	 observed	 in	 both	 groups	 of	 pregnant	women	
declaring	and	denying	supplementation,	what	further	supports	the	
conclusion	that	supplementation	at	400	IU/	daily	is	not	sufficient	
enough	to	significantly	rise	the	concentration	of	25OHD	in	serum	
[20].	
The	 dependence	 between	 obesity	 and	 vitamin	 D	 supply	
was	analyzed	on	 the	basis	of	BMI,	 calculated	according	 to	 the	
weight	 and	 height	 values	 obtained	 during	 the	 first	 visit	 of	 a	
pregnant	woman	(in	the	1st	trimester),	what	is	common	practice	
in	 population	 studies	 of	 pregnant	women	 [24].	The	first	 visit’s	
BMI	 is	usually	used	 for	practical	 reasons	as	 the	pre-pregnancy	
weight	declared	by	women	is	often	not	verifiable	[25].	Vitamin	
D	 level	 in	 the	 studied	 subjects,	 who	 were	 assigned	 in	 the	 1st 
trimester	 of	 pregnancy to	 either	 low-	 or	 high-BMI	 subgroups,	
revealed	significant	inverse	relationship	between	serum	25OHD	
concentration	and	BMI	(Table	IV).	That	effect	can	be	due	to	the	
mechanism	 of	 	 “sequestration”	 of	 vitamin	 D	 in	 the	 excess	 of	
adipose	tissue.	Our	results	support	the	data	that	obesity	may	lead	
to	poor	vitamin	D	status	during	pregnancy	[26,27]	and	focus	on	
the	problem	of	vitamin	D	 insufficiency	 in	overweight	pregnant	
women.	 It	 seems	 that	 more	 detailed	 studies	 on	 controlling	
vitamin	 D	 status	 and	 its	 supplementation	 in	 a	 large	 group	 of	
Polish	pregnant	women	should	be	conducted.	
Conclusions
Regardless	 of	 trimester	 and	 season,	 vitamin	 D	 below	 the	
optimal	 level	 is	 a	 common	 finding	 in	 pregnant	 residents	 of	
Warsaw.	The	current	level	of	supplementation	during	pregnancy	
through	multivitamin	tablets	(typically	containing	400	IU	vitamin	
D
3
)	in	Poland	appears	to	be	insufficient.	
Our	data	suggest	that	special	attention	should	be	paid	to	the	
issue	of	vitamin	D	insufficiency	in	overweight	pregnant	women.
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25OHD level Low BMI 
n=13/39
High BMI
n=14/42
25OHD [ng/ml] 
mean
sd
min
max
27.3*
7.6
12.9
47.3
23.5*
10.4
3.3
49.7
25OHD [%]
>30 ng/ml
20-30 ng/ml
10-20 ng/ml
<10 ng/ml
35.9
48.7
15.4
nd
23.8
40.5
23.8
11.9
nd – not detected
*p<0.05 (non-parametric U Mann-Whitney test)
